
Quantitative immunology & biological physics. Q-Immuno Lab PI @iit_ucl & @ucl_ipls past: Lewis-Sigler Fellow @Princeton, PhD @ENS_ULM Also @qimmuno.bsky.social
London, UK
Joined February 2014
- Tweets680
- Following879
- Followers1.2K
- Likes2.4K
When comparing clusterings, what makes a better solution?
In a new preprint, I describe homogeneity–parsimony curves as a means to quantify the underlying trade-off. Think of it as an ROC curve, but for clustering validation.
arxiv.org/abs/2607.20799
One month until London Q-Immuno Day 2026! 🧬💻
Join us on May 8th for interdisciplinary discussions at the intersection of theory, computation and immunology. 🥳
More details and free registration at: qimmuno.com/ldnday/
Andreas Tiffeau-Mayer retweeted
The Sim lab has been hard at work and we’re proud to present our first paper.
We developed new methods to study peptide:KIR interactions.
Congratulations to star postdoc Tanusya Murali who led the project.
biorxiv.org/content/10.64898…
How different are self and nonself? This is a central question in immunology.
In our latest work just published in @PRX_Life we demonstrate that at the peptide-level statistical differences between host and pathogen proteomes are minor
This Post is from an account that no longer exists. Learn more
An important implication for cancer treatment is that neoantigens that are just one mutation from self are not strange antigen at all, as sometimes thought.
Excited to share the latest preprint from the lab "Fluctuating environments are sufficient to drive substantial variability in species abundance across locations" now up on arXiv arxiv.org/abs/2603.02403 🎉
Our work on these questions has been motivated by our experimental findings uncovering substantial variation in the human immune repertoire across blood and tonsils. doi.org/10.1016/j.immuni.202…
If you're at @britsocimm Congress, come catch three talks today with updates about our research!
Later on I will give an invited talk in the session "AI driven insights into immune responses: vaccines, infections, and disease" laying out a vision for combining AI with TCRseq to study human immunity

